Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
08/13/2002 | US6432917 Anticancer agents |
08/13/2002 | US6432916 Compounds and methods for treatment and diagnosis of chlamydial infection |
08/13/2002 | US6432714 Reducing viral loads in hiv positive subjects and killing cells |
08/13/2002 | US6432707 Isolation of polynucleootide |
08/13/2002 | US6432703 Isolated polynucleotide sequences |
08/13/2002 | US6432679 Epstein-barr virus sequence binding to receptors, proteins, polypeptides, peptides or polysaccharides |
08/13/2002 | US6432675 Combinatorial polypeptide antigens |
08/13/2002 | US6432670 Amino acid sequence polypeptide |
08/13/2002 | US6432669 Protective recombinant Haemophilus influenzae high molecular weight proteins |
08/13/2002 | US6432666 Isolated human dendritic cell receptor with amino acid sequence |
08/13/2002 | US6432655 Binding and 5-ht receptors and gene expression |
08/13/2002 | US6432455 Symptomatic relief of allergic reactions |
08/13/2002 | US6432454 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
08/13/2002 | US6432412 Active immunization using a siderophore receptor protein |
08/13/2002 | US6432411 Recombinant envelope vaccine against flavivirus infection |
08/13/2002 | US6432409 Hybrid peptides modulate the immune response |
08/13/2002 | US6432408 Swine hepatitis E virus and uses thereof |
08/13/2002 | US6432404 Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies |
08/13/2002 | US6432402 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
08/13/2002 | US6432398 Methods of treating diseased cells |
08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
08/13/2002 | CA2122604C Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
08/13/2002 | CA2045594C Immunogenic compositions against gastrin peptides |
08/13/2002 | CA2019671C Oxidative denaturation of protein analytes |
08/08/2002 | WO2002061113A2 Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation |
08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
08/08/2002 | WO2002061090A2 Prokaryotically produced antibodies and uses thereof |
08/08/2002 | WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
08/08/2002 | WO2002061081A1 A novel gene bn01 mapping to chromosome 16q24.3 |
08/08/2002 | WO2002061070A2 Environmentally regulated genes, involved in the virulence of streptococcus suis |
08/08/2002 | WO2002061048A2 In vitro system for replication of rna-dependent rna polymerase (rdrp) viruses |
08/08/2002 | WO2002060955A2 Modified antibodies and methods of use |
08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
08/08/2002 | WO2002060938A2 Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof |
08/08/2002 | WO2002060937A1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
08/08/2002 | WO2002060936A2 Vaccine and compositions for the prevention and treatment of neisserial infections |
08/08/2002 | WO2002060935A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
08/08/2002 | WO2002060929A2 Polymer conjugates of neublastin and methods of using same |
08/08/2002 | WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
08/08/2002 | WO2002060921A2 Enhancement of immune response to vaccine by interferon alpha |
08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
08/08/2002 | WO2002060491A2 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
08/08/2002 | WO2002060485A2 Use of immunoregulatory antibodies in the treatment of neoplastic disorders |
08/08/2002 | WO2002060484A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
08/08/2002 | WO2002060482A2 Perylenequinones for use with immunotherapy agents |
08/08/2002 | WO2002060481A1 Methods for treating disease states comprising administration of low levels of antibodies |
08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |
08/08/2002 | WO2002060479A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease |
08/08/2002 | WO2002060478A1 Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies |
08/08/2002 | WO2002060477A1 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same |
08/08/2002 | WO2002060476A2 Tumor vaccine |
08/08/2002 | WO2002060470A1 Pyk2 phosphorylation by her3 induces tumor invasion |
08/08/2002 | WO2002060412A2 Stabilised polymeric aerosols for pulmonary gene delivery |
08/08/2002 | WO2002060390A2 Induction of immune responses to isoaspartyl-modified antigens |
08/08/2002 | WO2002060376A2 Induction of tolerance by apoptotic and/or necrotic cells |
08/08/2002 | WO2002046208A3 Method of producing biospecific molecules by protein trans-splicing |
08/08/2002 | WO2002040516A3 Helicobacter cysteine rich protein a (hcpa) and uses thereof |
08/08/2002 | WO2002029062A3 Cytokine proteins |
08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
08/08/2002 | WO2002024145A3 Antiviral substances from plant cuticular and epicuticular material |
08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
08/08/2002 | WO2002005851A3 Enhancement of the action of central and peripheral nervous system agents |
08/08/2002 | WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
08/08/2002 | WO2002000885A3 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
08/08/2002 | WO2002000695A3 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis |
08/08/2002 | WO2001097858A3 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
08/08/2002 | WO2001096380A3 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN |
08/08/2002 | WO2001096379A3 Immunization of dairy cattle with chimeric gapc protein against streptococcus infection |
08/08/2002 | WO2001095934A3 The use of plant oil-bodies in vaccine delivery systems |
08/08/2002 | WO2001092547A3 Modified bovine adenovirus having altered tropism |
08/08/2002 | WO2001092306A3 Therapeutic compounds for ovarian cancer |
08/08/2002 | WO2001091536A3 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
08/08/2002 | WO2001085972A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
08/08/2002 | WO2001085926A3 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate |
08/08/2002 | WO2001085784A9 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF |
08/08/2002 | WO2001085773A3 Luxo-sigma54 interactions and methods of use |
08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
08/08/2002 | WO2001079274B1 Tuberculosis antigens and methods of use thereof |
08/08/2002 | WO2001070941A3 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
08/08/2002 | WO2001068116A3 Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections |
08/08/2002 | WO2001068103A3 Treatment of herpes infection using immunomodulatory polynucleotide sequences |
08/08/2002 | WO2001068077A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
08/08/2002 | WO2001051523A3 Anti-angiogenic proteins and fragments and methods of use thereof |
08/08/2002 | WO2001034802A9 Compositions and methods for the therapy and diagnosis of prostate cancer |
08/08/2002 | WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1 |
08/08/2002 | WO2001031011A9 Gene mining system and method |
08/08/2002 | WO2001023604A3 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
08/08/2002 | WO2001021799A9 Traf4 associated cell cycle proteins, compositions and methods of use |
08/08/2002 | WO2001016330A3 Prevention of affections associated with porcine circovirus-2 |
08/08/2002 | WO2001013714A3 Prostatic cell line and animal model of a prostatic tumor |
08/08/2002 | WO2001008703A9 Recombinant rsv virus expression systems and vaccines |
08/08/2002 | WO2001008636A8 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
08/08/2002 | US20020107869 Novel implant and novel vector for the treatment of acquired diseases |
08/08/2002 | US20020107389 Compound for use in the treatment of autoimmune diseases |